摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

有机杂环化合物

下级分类

中文名称 英文名称 CAS号 化学式 结构式图片
IN1273,5,5'-二溴-3,3'-双(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)-2,2'-联噻吩 5,5'-dibromo-3,3'-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-2,2'-bithiophene 1974310-58-1 C22H32Br2O8S2
IN1273,5,5'-二溴-3,3'-双(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)-2,2'-联噻吩
IMEGLIMIN盐酸盐 imeglimin hydrochloride 352211-11-1 C6H13N5*ClH
IMEGLIMIN盐酸盐
IM-017(9-[(R)-2-{9'-腺嘌呤基[R)-2-丙基)]}-磷酰甲氧基丙基]-腺嘌呤) [[(2R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl]phosphonic Acid Mono[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl] Ester 1878175-77-9 C17H23N10O4P
IM-017(9-[(R)-2-{9'-腺嘌呤基[R)-2-丙基)]}-磷酰甲氧基丙基]-腺嘌呤)
IKKε-IN-1抑制剂 5-[2-[(4-morpholinophenyl)amino]pyrimidin-4-yl]-2-tetrahydropyran-4-yloxy-benzonitrile 1292310-49-6 C26H27N5O3
IKKε-IN-1抑制剂
HY-16997 (INCB3911) {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile 1334298-90-6 C26H23F4N9O
HY-16997 (INCB3911)
HSP90抑制剂(VER-49009) VER 49009 940289-57-6 C19H18ClN3O4
HSP90抑制剂(VER-49009)
HSD抑制剂23 N-[(E)-5-hydroxy-2-adamantyl]-2-methyl-2-{4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}propanamide 868604-75-5 C24H33F3N4O2
HSD抑制剂23
HOECHST33258类似物5,BR 2'-(naphth-2-yl)-5-(4-methylpiperazinyl)-2,5'-bi-1H-benzimidazole 23491-55-6 C29H26N6
HOECHST33258类似物5,BR
HOECHST33258类似物2 2'-m-tolyl-5-(4-methylpiperazinyl)-2,5'-bi-1H-benzimidazole 23491-54-5 C26H26N6
HOECHST33258类似物2
HG2+汞离子探针 rhodamine B thiospirolactone 111883-10-4 C28H30N2O2S
HG2+汞离子探针
HC棕NO.2 3-[[4-[[Diamino(phenylazo)phenyl]azo]-m-tolyl]azo]-N,N,N-trimethylanilinium chloride 83803-99-0 C28H30ClN9
HC棕NO.2
HC棕NO.1 3-[[4-[[Diamino(phenylazo)phenyl]azo]-1-naphthyl]azo]-N,N,N-trimethylanilinium chloride 83803-98-9 C31H30ClN9
HC棕NO.1
HC 黄 7 HC Yellow NO. 7 104226-21-3 C17H22N4O2
HC 黄 7
HA-1004二盐酸盐 N-(2-Guanidinoethyl)-5-isoquinolinesulfonamide 91742-10-8 C12H15N5O2S
HA-1004二盐酸盐
HA 1004 盐酸盐 HA 1004 hydrochloride 92564-34-6 C12H15N5O2S*ClH
HA 1004 盐酸盐
H-咪唑[1,2-A]吡啶-5-羧酸 imidazo[1,2-a]pyridine-5-carboxylic acid 479028-72-3 C8H6N2O2
H-咪唑[1,2-A]吡啶-5-羧酸
H-吡咯并[1,2-F]嘧啶-3-甲酸 pyrrolo[1,2-c]pyrimidine-3-carboxylic acid 251102-27-9 C8H6N2O2
H-吡咯并[1,2-F]嘧啶-3-甲酸
H-8 二氢氯化物 hydron;N-[2-(methylamino)ethyl]isoquinoline-5-sulfonamide;dichloride —— C12H17Cl2N3O2S
H-8 二氢氯化物
H-7二盐酸盐 hydron;5-(2-methylpiperazin-1-yl)sulfonylisoquinoline;dichloride —— C14H19Cl2N3O2S
H-7二盐酸盐
Gardenine;[2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-六氢-2a-羟基-1-氧杂-7-氮杂环戊并[cd]茚-5-羧酸甲酯 Gardenine 139682-36-3 C11H13NO4
Gardenine;[2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-六氢-2a-羟基-1-氧杂-7-氮杂环戊并[cd]茚-5-羧酸甲酯
GarcinoneC;1,3,6,7-四羟基-8-(3-羟基-3-甲基丁基)-2-(3-甲基-2-丁烯-1-基)-9H-呫吨-9-酮 garcinone C 76996-27-5 C23H26O7
GarcinoneC;1,3,6,7-四羟基-8-(3-羟基-3-甲基丁基)-2-(3-甲基-2-丁烯-1-基)-9H-呫吨-9-酮
GYKI52466,盐酸盐 GYKI 52466 hydrochloride 192065-56-8 C17H16ClN3O2
GYKI52466,盐酸盐
GYKI-53655水合物 5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide;hydron;chloride 143692-48-2 C19H21ClN4O3
GYKI-53655水合物
GW627368X抑制剂 N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide 439288-66-1 C30H28N2O6S
GW627368X抑制剂
GW405833盐酸盐 (2,3-dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone 180002-83-9 C23H24Cl2N2O3
GW405833盐酸盐
GTx-134; 2-[4-[[(2R)-3-(2,4-二甲基苯氧基)-2-羟基丙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-6,7-二氢-6-[1-[2-(甲磺酰基)乙基]-4-哌啶基]吡咯并[3,4-f]苯并咪唑-5(3H)-酮 2-{4-[(R)-3-(2,4-dimethylphenoxy)-2-hydroxypropylamino]-2-oxo-1,2-dihydropyridin-3-yl}-6-[1-(2-methanesulfonylethyl)piperidin-4-yl]-6,7-dihydro-3H-1,3,6-triaza-s-indacen-5-one 1008448-19-8 C33H40N6O6S
GTx-134; 2-[4-[[(2R)-3-(2,4-二甲基苯氧基)-2-羟基丙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-6,7-二氢-6-[1-[2-(甲磺酰基)乙基]-4-哌啶基]吡咯并[3,4-f]苯并咪唑-5(3H)-酮
GSKPERK抑制剂 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone 1337531-89-1 C24H19F4N5O
GSKPERK抑制剂
GSK789472盐酸盐 1-Phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride 1257326-24-1 C15H22ClN3O
GSK789472盐酸盐
GSK256066三氟乙酸盐 GSK256066 2,2,2-trifluoroacetic acid 1415560-64-3 C29H27F3N4O7S
GSK256066三氟乙酸盐
GSK2334470游离态 GKS2334470 1227911-45-6 C25H34N8O
GSK2334470游离态
GSK2193874游离态 GSK2193874 1336960-13-4 C37H38BrF3N4O
GSK2193874游离态
GSK-3抑制剂(LY2090314) 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine 603288-22-8 C28H25FN6O3
GSK-3抑制剂(LY2090314)
GSK-3beta 抑制剂 XI GSK-3b Inhibitor XI 626604-39-5 C18H15N5O3
GSK-3beta 抑制剂 XI
GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺 I-BET762 1260907-17-2 C22H22ClN5O2
GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺
GSK 189254; 6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐 [3H]-GSK189254 945493-87-8 C21H25N3O2*ClH
GSK 189254; 6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐
GSK 1292263 盐酸盐 5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine hydrochloride 1032824-54-6 C23H28N4O4S*ClH
GSK 1292263 盐酸盐
GSK 1059615; (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 GSK1059615 958852-01-2 C18H11N3O2S
GSK 1059615; (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮
GRANULAR BLUE 粒蓝相似物 2-<4-(4-Amidinophenoxy)phenyl>indol-6-carboxamidin-dihydrochlorid 55453-00-4 C22H19N5O*2ClH
GRANULAR BLUE 粒蓝相似物
GPR84拮抗剂8 2-([1,4]dioxan-2-ylmethoxy)-9-(pyridin-2-ylmethoxy)-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one 1445846-30-9 C23H23N3O5
GPR84拮抗剂8
GPR109A受体激动剂(MK-0354) MK-0354 851776-28-8 C7H8N6
GPR109A受体激动剂(MK-0354)
GNF179代谢物 2-(4-Fluorophenyl)-8,8-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine 1310455-86-7 C14H16FN3
GNF179代谢物
GNE-495游离态 8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide 1449277-10-4 C22H20FN5O2
GNE-495游离态
GNE-477抑制剂 GNE-477 1032754-81-6 C21H28N8O3S2
GNE-477抑制剂
GNE-0877抑制剂 2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile 1374828-69-9 C14H16F3N7
GNE-0877抑制剂
GLPG0187,一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性 L-Alanine, 3-((2,5-dimethyl-6-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl)-4-pyrimidinyl)amino)-N-((4-methoxyphenyl)sulfonyl) 1320346-97-1 C29H37N7O5S
GLPG0187,一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性
GLPG-0634 中间体 N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide 1142943-96-1 C10H9BrN4O
GLPG-0634 中间体
GJ103游离 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid 1459687-89-8 C16H14N4O3S
GJ103游离
GJ-103钠盐 sodium 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetate 1459687-96-7 C16H13N4O3S*Na
GJ-103钠盐
GENZ-644282抑制剂 2,3-dimethoxy-12-(2-(methylamino)ethyl)[1,3]dioxolo[4',5':4,5]-benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one 529488-28-6 C22H21N3O5
GENZ-644282抑制剂
GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲 (S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea 1207360-89-1 C24H32N6O3
GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲